- Last edited on March 6, 2021
Differences
This shows you the differences between two versions of the page.
|
meds:mood-stabilizers-anticonvulsants:carbamazepine [on March 21, 2020] |
meds:mood-stabilizers-anticonvulsants:carbamazepine [on March 21, 2020] |
||
|---|---|---|---|
| Line 23: | Line 23: | ||
| ===== Dose ===== | ===== Dose ===== | ||
| - | 100-1200mg (using the CR formulation) | + | The dose range for carbamazepine is between 100-1200mg (using the CR formulation), and it is usually dosed BID. Carbamazepine can be increased by 100 mg every 2-3 days as tolerated, up to an initial target dose of at least 300 mg/day. After at least 5 days at this target dose (to allow steady state to be achieve), a carbamazepine level should be drawn 12 hours after the last dose. If the level is: |
| - | + | ||
| - | Carbamazepine can be increased by 100 mg every 2-3 days as tolerated, up to an initial target dose of at least 300 mg/day. After at least 5 days at this target dose (to allow steady state to be achieve), a carbamazepine level should be drawn 12 hours after the last dose. If the level is: | + | |
| * <17 μmol/L, then the dose should be increased by 100 mg/day and another level should be drawn in 5 days | * <17 μmol/L, then the dose should be increased by 100 mg/day and another level should be drawn in 5 days | ||
| * 17-54 μmol/L, then the dose can be maintained | * 17-54 μmol/L, then the dose can be maintained | ||